ArticleFrontiers in genetics2022

Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study.

YouZhi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.